Vulnerability in Philips Clinical Collaboration Platform
CVE-2020-16198
When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 5.0 (Medium). Vector: CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:L.
EPSS exploit prediction
EPSS: 0.006 (46.2th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 46th percentile — 46.2% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: 0.000
Affected products
Weakness classification (CWE)
References
- us-cert.cisa.gov/ics/advisories/icsma-20-261-01 (US Government Resource, Third Party Advisory)
- www.philips.com/a-w/security/security-advisories/product-security-2020.html
Frequently asked questions
- What is CVE-2020-16198?
- CVE-2020-16198 is a medium-severity vulnerability in Philips Clinical Collaboration Platform, classified under Protection Mechanism Failure. CVSS score: 5.0/10. Published 2020-09-18.
- How severe is CVE-2020-16198?
- Medium severity. CVSS v3 base score is 5.0 out of 10.